Stocks
Integra LifeSciences Holdings Corporation (IART) EBITDA margin US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA margin, % | ? | 23.7% | 24.7% | 16.6% | 12.0% | -19.9% | -16.6% | |
| Changes by years, y/y, % | +4pp | +1pp | -8pp | -5pp | -32pp | |||
Integra LifeSciences Holdings Corporation. EBITDA margin, %
Integra LifeSciences Holdings Corporation. EBITDA margin, changes, pp
Integra LifeSciences Holdings Corporation (IART) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 6.79% | -113.6% | 13.4% | 15.2% | 20.0% | -16.6% | |
| Changes by years, y/y, % | -4pp | -123pp | +4pp | -3pp | +13pp | |||
| Changes by quarters, q/q, % | -11pp | -120pp | +127pp | +2pp | +5pp | |||
